CAADPE Blog

News

SB 641 Bill to Prevent Opioid Deaths Vetoed by Governor Newsom 

Governor Gavin Newsom has vetoed Senate Bill 641 by Senator Richard Roth (D-Riverside), which would have helped ensure that those who administer overdose reversal medications have the best chance at saving lives. Learn more in the Press Release from CAADPE and the Riverside County Sheriff’s Office.

Read More >>

Act Now for a Safer California: Help Urge Governor Newsom to Sign SB 641

Law enforcement officials, behavioral health advocates, families affected by overdoses, and addiction medicine professionals in California are urging Governor Gavin Newsom to sign Senate Bill 641 into law. See the Press Releaseand find how rich elected officials.

Read More >>

CAADPE In-Person Meeting: Fri., Sept. 29

The first of our in-person quarterly meetings will be held on Friday, September 29, at CRI-Help in North Hollywood. Get the details…

Read More >>

DHCS Issues Updated FAQs on Documentation Requirements

The Department has updated its Frequently Asked Questions (FAQs) about documentation requirements for all Specialty Mental Health Services (SMHS), Drug Medi-Cal (DMC), and Drug Medi-Cal Organized Delivery System (DMC-ODS). Updates…

Read More >>

The Governor Agrees To Some Changes In His BH Modernization Proposal

In response to concerns from counties and advocates, Governor Newsom has made some concessions in his plan to reform the behavioral health care system and the Mental Health Services Act,…

Read More >>

Secured Residential Treatment Facility Bill Advances Despite Opposition

AB 1360, by Assemblyman Kevin McCarty (D-Sacramento), authorizes the Counties of Sacramento and Yolo to offer secured residential treatment pilot programs for individuals suffering from substance use disorders who have…

Read More >>

CAADPE Seeks Support for Co-Sponsored Bill on Naloxone Distribution

SB 641 (Roth), co-sponsored by CAADPE and the Riverside County Sheriff’s Department, would require DHCS, as part of the Naloxone Distribution Project (NDP), to make all FDA-approved formulations and dosage…

Read More >>